Search information leaflets for human, veterinary and plants medications, drugs, supplements, herbal, nutritional and homoeopathic products;

Circovac

Circovac

Marketed by: Merial
Active ingredient: inactivated porcine circovirus type 2 (PCV2)

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Cimalgex

Cimalgex

Marketed by: Vétoquinol SA
Active ingredient: cimicoxib

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Certifect

Certifect

Marketed by: Merial
Active ingredient: fipronil / amitraz / (S)-methoprene

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Cerenia

Cerenia

Marketed by: Zoetis Belgium SA
Active ingredient: maropitant citrate

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Insulatard

Insulatard

Marketed by: Novo Nordisk A/S
Active ingredient: insulin human

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Instanyl

Instanyl

Marketed by: Takeda Pharma A/S
Active ingredient: fentanyl citrate

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Inovelon

Inovelon

Marketed by: Eisai Ltd
Active ingredient: rufinamide

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

INOmax

INOmax

Marketed by: Linde Healthcare AB
Active ingredient: nitric oxide

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Inlyta

Inlyta

Marketed by: Pfizer Ltd
Active ingredient: axitinib

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Inhixa

Inhixa

Marketed by: Techdow Europe AB
Active ingredient: enoxaparin sodium

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Inflectra

Inflectra

Marketed by: Hospira UK Limited
Active ingredient: infliximab

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Infanrix Penta

Infanrix Penta

Marketed by: GlaxoSmithKline Biologicals S.A.
Active ingredient: diphtheria toxoid / tetanus toxoid / Bordetella pertussis antigens (pertussis toxoid, filamentous haemagglutinin, pertactin) / hepatitis-B surface antigen / poliovirus (inactivated) (type 1 (Mahoney s...

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Infanrix Hexa

Infanrix Hexa

Marketed by: GlaxoSmithKline Biologicals S.A.
Active ingredient: diphtheria toxoid / tetanus toxoid / Bordetella pertussis antigens (pertussis toxoid, filamentous haemagglutinin, pertactin) / hepatitis B surface antigen / poliovirus (inactivated) (type-1 (Mahoney s...

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Inductos

Inductos

Marketed by: Medtronic BioPharma B.V.
Active ingredient: dibotermin alfa

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Incruse

Incruse

Marketed by: Glaxo Group Ltd
Active ingredient: umeclidinium bromide

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Incresync

Incresync

Marketed by: Takeda Pharma A/S
Active ingredient: alogliptin / pioglitazone

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Increlex

Increlex

Marketed by: Ipsen Pharma
Active ingredient: mecasermin

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Incivo

Incivo

Marketed by: Janssen-Cilag International N.V.
Active ingredient: telaprevir

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Imvanex

Imvanex

Marketed by: Bavarian Nordic A/S
Active ingredient: modified vaccinia Ankara - Bavarian Nordic (MVA-BN) virus

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Impulsor

Impulsor

Marketed by: Pierre Fabre Medicament
Active ingredient: milnacipran

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Imprida HCT

Imprida HCT

Marketed by: Novartis Europharm Ltd.
Active ingredient: amlodipine / valsartan / hydrochlorothiazide

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Imprida

Imprida

Marketed by: Novartis Europharm Ltd
Active ingredient: amlodipine (as besylate) / valsartan

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Imnovid (previously Pomalidomide Celgene)

Imnovid (previously Pomalidomide Celgene)

Marketed by: Celgene Europe Ltd
Active ingredient: pomalidomide

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

ImmunoGam

ImmunoGam

Marketed by: Cangene Europe Limited
Active ingredient: human hepatitis B immunoglobulin

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Imlygic

Imlygic

Marketed by: Amgen Europe B.V.
Active ingredient: talimogene laherparepvec

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Imbruvica

Imbruvica

Marketed by: Janssen-Cilag International NV
Active ingredient: ibrutinib

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Imatinib Teva

Imatinib Teva

Marketed by: Teva B.V.
Active ingredient: imatinib

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Imatinib medac

Imatinib medac

Marketed by: Medac
Active ingredient: imatinib

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Imatinib Actavis

Imatinib Actavis

Marketed by: Actavis Group PTC ehf
Active ingredient: imatinib

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Imatinib Accord

Imatinib Accord

Marketed by: Accord Healthcare Ltd
Active ingredient: imatinib

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Cepedex

Cepedex

Marketed by: CP-Pharma Handelsgesellschaft mbH
Active ingredient: dexmedetomidine hydrochloride

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Ilaris

Ilaris

Marketed by: Novartis Europharm Ltd
Active ingredient: canakinumab

Available in: European Union
Language: English
Source: EMA - European Medicines Agency